Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biotrove

1997 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
1 INVESTORS
Description

Provider of technology platforms for life science and drug discovery research. The company's technology platforms include RapidFire, which helps in drug discovery and pipeline decisions and OpenArray, which aids genomic research in various life science fields, including agriculture, disease research, bio-defense and public health. Its other products perform PCR based SNP analysis of samples against candidate SNPs, develop and screen assays for intractable drug targets, analyze Cytochrome P450 inhibition for in vitro ADME and handle liquid and prepare online samples for mass spectrometry.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • 12 Gill Street
  • Suite 4000
  • Woburn, MA 01801
  • United States

+1 (781) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Biotrove’s full profile, request a free trial.

Biotrove Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 15-Dec-2009 000.00 Completed Generating Revenue
10. Later Stage VC (Series C1) 25-Feb-2009 000.00 000.00 00000 Completed Generating Revenue
9. IPO 18-Dec-2008 0000 Cancelled Generating Revenue
8. Convertible Debt 04-Sep-2008 000.00 000.00 Completed Generating Revenue
7. Convertible Debt 29-Aug-2007 00.00 000.00 Completed Generating Revenue/Not Profitable
6. Later Stage VC (Series B1) 28-Feb-2006 000 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 14-Jul-2005 000 000.00 Completed Generating Revenue
4. Debt - General 08-Jun-2005 000 000.00 Completed Generating Revenue
3. Debt - General 02-Dec-2004 $75K $13.8M Completed Product Development
2. Early Stage VC (Series B) 14-Apr-2004 $13.7M $13.7M 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Biotrove Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 00,000,000 00.000000 00 00 00.0 00 00 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 45,802 $0.010000
Series A 250,000 $0.010000
To view this company’s complete Cap Table, request access »

Biotrove Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioFrontier Partners Venture Capital Minority 000 0000 000000 0
CB Health Ventures Venture Capital Minority 000 0000 000000 0
Catalyst Health Ventures Venture Capital Minority 000 0000 000000 0
Echelon Ventures Venture Capital Minority 000 0000 000000 0
Excel Venture Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »